US Patent Issued to Immatics Biotechnologies on Feb. 18 for "Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods" (German Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,556, issued on Feb. 18, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods" was invented by Gisela Schimmack (Tuebingen, Germany), Annika Sonntag (Tuebingen, Germany), Heiko Schuster (Tuebingen, Germany), Daniel Johannes Kowalewski (Tuebingen, Germany), Michael Roemer (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Toni Weinschenk (Tuebingen, Germany) and Harpreet Singh (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, pro...